In the specialized field of bio by P Schulz-Knappe·2000·Cited by 2003—The discovery ofLEAP-. 1 extends the known families of mammalian peptideswith antimicrobial activity by its novel disulfide motif and distinct expression Read more chemical research, the exploration of signaling molecules and their structural motifs remains a cornerstone of discov Liver-expressed antimicrobial peptide 2 is a hepatokine ery. Among these, the LEAP 1 peptide—frequently identified in scientific literature as Hepcidin—represents a fascinating subject for those interested in molecular biology and protein chemistry. My engagement with this compound has been strictly limited to understanding its role as a research tool, focusing on its unique chemical architecture and its classification as a liver-expressed antimicrobial peptide.
Chemical Composition and Structural Characteristics
When analyzing the LEAP 1 peptide, it is essential to recognize that Hepcidin is a cationic, cysteine-rich and tightly folded peptide. Its stability is largely attributed to four disulfide bonds, which define its tertiary structure. As a novel peptide, its discovery significantly expanded the known families of mammalian peptides with antimicrobial activity.
From a structural perspective, the Human Hepcidin-25 peptide consists of 25 amino acid residues. Its sequence, often studied by those sourcing the material from a global supplier of Hepcidin/LEAP-1 (Human), reveals a complex, highly disulfide-bonded human peptide. The specificity of this structure is why researchers Hepcidin-25 (human) often seek high-purity variants for their experimental models.
Biological Context and Function
The nomenclature itself—LEAP-1—stands for "Liver-Expressed Antimicrobial Peptide 1." This aligns with the fact that LEAP-1 is a liver-specific peptide and is predominantly expressed in the liver. Beyond its antimicrobial properties, Hepcidin is a peptide hormone that seems to act as a signaling molecule involved in the maintenance of iron homeostasis.
In my own review of available documentation, it is clear that Hepcidin-25 (hepatic bactericidal protein), also referred to as LEAP-1, serves as a critical focus for laboratories investigating iron regulation. Whether one is evaluating Hepcidin/LEAP-1 (Human) for biochemical assays or structural characterization, the precision of the peptide's synthesis is paramount.
Distinctions in Research Applications
It is important not to conflate this molecule with other similarly named compounds. For example, while LEAP-2 exhibits antimicrobial activity against microbial model organisms and is often studied in the context of metabolic signaling, it is a distinct entity from the LEAP-1/Hepcidin Hepcidin-25 (human) complex. Furthermore, compounds like the LyP-1 peptide—which is detected in tumor structures that are positive for several lymphatic endothelial markers—serve entirely different research purposes.
When acquiring a Human Hepcidin peptide hormone product, researchers must ensure they are working with the correct sequence. The Hepcidin/LEAP-1, Active Peptide is a sophisticated tool, and when dealing with such a complex molecule, the purity and the in Hepcidin-25(human) | C113H170N34O31S9 | CID 90472084 tegrity of the disulfide bonds are the primary metrics of quality.
Practical Considerations for Researchers
If you are looking for Hepcidin/LEAP-1 (Human) for your facility, it is helpful to note that this is a specialized reagent. Because Hepcidin, also known as LEAP-1, is a highly specific marker, the availability of Hepcidin-25 (human) in synthetic form allows for consistent results in ELISA or binding ligand studies.
The LEAP-1/hepcidin axis remains a vital area of inquiry. Whether you are referencing Liver-expressed anti microbial peptide (LEAP)-1/hepcidin or simply conducting general protein detection, the application of this peptide must always be handled with the rigor expected in a professional laboratory setting. By maintaining a focus on the structural, chemical, and signaling properties of the molecule, by MN Islam·2024·Cited by 15—LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480, 147–150 (2000). Article CAS PubMed Read more researchers can continue to leverage the LEAP 1 peptide as a reliabl by P Schulz-Knappe·2000·Cited by 2003—The discovery ofLEAP-. 1 extends the known families of mammalian peptideswith antimicrobial activity by its novel disulfide motif and distinct expression Read more e instrument in the advancement of biological science.